MHRA Drug Safety Update May 2022
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 10 May 2022) has been published and includes articles on: Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia COVID-19 vaccines and medicines: updates for May 2022 Letters and medicine...
Recent Comments